Karas Eric 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Karas Eric（CIK 1951287）在 1 家公司共报告 6 笔 SEC Form 4 内部人交易（最近一笔 2026-06-12）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-06-12 | ARS Pharmaceuticals, Inc. (SPRY) | Chief Commercial Officer | 买入 | 25,000 | $37,500 |
| 2026-06-12 | ARS Pharmaceuticals, Inc. (SPRY) | Chief Commercial Officer | 卖出 | 25,000 | $250,000 |
| 2025-07-03 | ARS Pharmaceuticals, Inc. (SPRY) | Chief Commercial Officer | 买入 | 15,000 | $22,500 |
| 2025-07-03 | ARS Pharmaceuticals, Inc. (SPRY) | Chief Commercial Officer | 卖出 | 15,000 | $254,850 |
| 2025-06-20 | ARS Pharmaceuticals, Inc. (SPRY) | Chief Commercial Officer | 买入 | 15,000 | $22,500 |
| 2025-06-20 | ARS Pharmaceuticals, Inc. (SPRY) | Chief Commercial Officer | 卖出 | 15,000 | $240,000 |
来源：SEC Form 4 申报文件 · 截至 2026-06-12